A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Pneumococcal Carriage Duration
- Status
- RECRUITING
- Phase
- N/A
A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Genitourinary Tumors With Sacituzumab Tirumotecan
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of V132 in Healthy Older Participants (V132-001)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Letermovir for R+ Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Characterization, Health Resource Utilization and Biomarkers in Early-stage
- Status
- RECRUITING
- Phase
- N/A
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2